These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 19117936)

  • 1. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.
    Seddon JM; Reynolds R; Maller J; Fagerness JA; Daly MJ; Rosner B
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2044-53. PubMed ID: 19117936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration.
    Seddon JM; Francis PJ; George S; Schultz DW; Rosner B; Klein ML
    JAMA; 2007 Apr; 297(16):1793-800. PubMed ID: 17456821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans.
    Contreras AV; Zenteno JC; Fernández-López JC; Rodríguez-Corona U; Falfán-Valencia R; Sebastian L; Morales F; Ochoa-Contreras D; Carnevale A; Silva-Zolezzi I
    Mol Vis; 2014; 20():105-16. PubMed ID: 24453474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population.
    Buentello-Volante B; Rodriguez-Ruiz G; Miranda-Duarte A; Pompa-Mera EN; Graue-Wiechers F; Bekker-Méndez C; Ayala-Ramirez R; Quezada C; Rodríguez-Loaiza JL; Zenteno JC
    Mol Vis; 2012; 18():2518-25. PubMed ID: 23112567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.
    Seddon JM; Reynolds R; Yu Y; Daly MJ; Rosner B
    Ophthalmology; 2011 Nov; 118(11):2203-11. PubMed ID: 21959373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study.
    Roshanipour N; Laleh MG; Bonyadi M; Bonyadi MHJ; Soheilian M; Javadzadeh A; Yaseri M
    BMC Ophthalmol; 2020 Aug; 20(1):323. PubMed ID: 32762675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors.
    Chen Y; Zeng J; Zhao C; Wang K; Trood E; Buehler J; Weed M; Kasuga D; Bernstein PS; Hughes G; Fu V; Chin J; Lee C; Crocker M; Bedell M; Salasar F; Yang Z; Goldbaum M; Ferreyra H; Freeman WR; Kozak I; Zhang K
    Arch Ophthalmol; 2011 Mar; 129(3):344-51. PubMed ID: 21402993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates.
    Seddon JM; Silver RE; Kwong M; Rosner B
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2192-202. PubMed ID: 25655794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
    Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
    JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
    Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
    Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic variants rs641153 (
    Neto JM; Viturino MG; Ananina G; Bajano FF; Costa SMDS; Roque AB; Borges GF; Franchi R; Rim PH; Medina FM; Costa FF; Melo MB; de Vasconcellos JP
    Exp Biol Med (Maywood); 2021 Nov; 246(21):2290-2296. PubMed ID: 34233521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between vitamin D status and age-related macular degeneration by genetic risk.
    Millen AE; Meyers KJ; Liu Z; Engelman CD; Wallace RB; LeBlanc ES; Tinker LF; Iyengar SK; Robinson JG; Sarto GE; Mares JA
    JAMA Ophthalmol; 2015 Oct; 133(10):1171-9. PubMed ID: 26312598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment model for development of advanced age-related macular degeneration.
    Klein ML; Francis PJ; Ferris FL; Hamon SC; Clemons TE
    Arch Ophthalmol; 2011 Dec; 129(12):1543-50. PubMed ID: 21825180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies.
    Seddon JM; Reynolds R; Rosner B
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):586-91. PubMed ID: 18936151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a prediction algorithm for progression to advanced macular degeneration subtypes.
    Seddon JM; Reynolds R; Yu Y; Rosner B
    JAMA Ophthalmol; 2013 Apr; 131(4):448-55. PubMed ID: 23411794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration.
    Seddon JM; George S; Rosner B; Klein ML
    Hum Hered; 2006; 61(3):157-65. PubMed ID: 16816528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration.
    Klein ML; Francis PJ; Rosner B; Reynolds R; Hamon SC; Schultz DW; Ott J; Seddon JM
    Ophthalmology; 2008 Jun; 115(6):1019-25. PubMed ID: 18423869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.